Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or emb...
Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Immune rejection may limit the therapeutic use of induced pluripotent stem cells (iPSCs); here, terminally differentiated mouse iPSCs are shown to generate negligible immune rejection in their host.
No immune reaction to iPSCs
Induced pluripotent stem cells (iPSCs) derived from a patient's own somatic cells could have great therapeutic potent...
Alternative Titles
Full title
Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1321123200
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1321123200
Other Identifiers
ISSN
0028-0836
E-ISSN
1476-4687
DOI
10.1038/nature11807
